Log In
BCIQ
Print this Print this
 

MaterniT GENOME

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
DescriptionNon-invasive prenatal test to detect trisomy 21, 18 and 13, sex chromosome aneuploidies, fetal sex, genome-wide copy variants of >=7 Mb and select deletions of <7 Mb
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect genome-wide fetal abnormalities
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$302.0M

$302.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/07/2016

$302.0M

$302.0M

0

Get a free BioCentury trial today